(as of 07/97)
2. Pick, C. G. and Yanai, J., Long term reduction in spontaneous
alterations after early exposure to phenobarbital. Int. J. Dev.
Neuroscience 2:223-228 (1984).
1. Pick, C. G. and Yanai, J., Eight-arm maze for mice. Int. J. Neuroscience
21:63-66 (1983).
2. Pick, C. G. and Yanai, J., Long term reduction in spontaneous
alterations after early exposure to phenobarbital. Int. J. Dev.
Neuroscience 2:223-228 (1984).
3. Pick, C. G. and Yanai, J., Long-term reduction in eight arm maze
performance after early exposure to phenobarbital. Int. J. Dev.
Neuroscience 3:223-227 (1985).
4. Lieblich, I., Baum, M. G., Diamond, P., Goldblom, N., Iser, C. and Pick,
C. G., Inhibition of mating by naloxone or morphine in recently castrated,
but not intact male rats. Pharmacology Biochemistry Behavior 22:361-364
(1985).
5. Yanai, J., Iser, C., Kleinberger N., and Pick, C. G., Mechanism of the
phenobarbital effect on CNS development: A potential model for
intervention. In: D. Tamir, T.B. Breazelton and A. Russel (eds.)
Stimulation and Intervention in Infant Development. pp. 405-412,
Freund/London (1986).
6. Yanai, J., C.G. Pick, D. Weinstein and A. McRae-Degueurce. The use of
brain tissue transplantation in neuroteratological studies.
NeuroToxicology, 7:141-146 (1986).
7. Yanai, J., C.G. Pick and C. Iser. Chronic treatment with haloperidol
affect the response of the brain to pentobarbital. Neuropharmacology,
25:943-945 (1986).
8. Yanai, J., C.G. Pick and A. McRae-Degueurce. Reversal of phenobarbital-
induced behavioral birth defects in mice by brain tissue transplantation.
In: Schenker J. G. and D. Weinstein. (Eds.) The Intrauterine Life-
Management and Therapy. pp. 389-393, Elsevier/Amsterdam (1986).
9. Yanai, J., Z. Greenfeld, U. Laxer, C.G. Pick, D. Trombka, D. Weinstein
and A . McRae-Degueurce. CNS changes after early barbiturate exposure:
mechanisms and reversal. In: T. Fujii and P.M. Adams. (eds.) Functional
Teratogenesis, pp. 121-130, Tokyo-University Press/Tokyo (1987).
10. Yanai, J., Z. Greenfeld, C.G. Pick and D. Trombka. Cholinergic mechanisms of behavioral deficits after prenatal exposure to phenobarbital. In: S. Cohen and M. Sokolovsky. (eds.) International Symposium on Muscarinic Cholinergic Mechanisms. pp. 374-378, Freund/ London (1987).
11. Yanai, J., and C.G. Pick . Studies on noradrenergic alternations in relation to early phenobarbital-induced behavioral changes. Int. J. Devl. Neuroscience. 5:337-344 (1987).
12. Pick, C.G., M. Statter, D. Ben-Shachar, M.B.H. Youdim and J. Yanai. Iron and zinc concentrations in mice after early exposure to phenobarbital. Int. J. Dev. Neuroscience. 5:391-398 (1987)
13. Yanai, J., A. Bergman, M. Keltz and C.G. Pick. Mechanisms of sensitivity and tolerance to and physical dependence on ethanol and barbiturates. In: J. Yanai, R. Bauml, P. Eldar and J. M. Rosenfeld. (Eds.) Alcohol Dependence, The Family and The Community. pp. 143-158, Freund/London (1988).
14. Yanai, J. and C.G. Pick. Neuron transplantation reverses phenobarbital- induced behavioral birth defects in mice. Int. J. Dev. Neuroscience. 6:409-416 (1988).
15. Kaspi, A., J. Yanai, C.G. Pick and G. Mann. Entrapment of the distal suprascapular nerve: an anatomical study. International Orthopaedics. 12:273- 275 (1988).
16. Pick, C.G. and J. Yanai. Studies into the mechanisms of strain differences in hippocampal related behaviors. Behavior Genetics. 19:315-325 (1989).
17. Yanai, J., U. Laxer, C. G. Pick and D. Trombka. Dopaminergic denervation reverses behavioral deficits induced by prenatal exposure to phenobarbital. Dev. Brain Research. 48:255-261 (1989).
18. Yanai, J, F. Fares, M. Gavish, Z. Greenfeld, C. G. Pick, Y. Rogel-Fuchs and D. Trombka. Two approaches for the reversal phenobarbital- induced behavioral birth defects. In: F. Gage, A. Privat and Y. Christen. (Eds.) Neuronal Grafting and Alzheimer's Disease. pp. 165-176, Springer- Verlag/Berlin Heidelberg (1989).
19. Yanai, J., F. Fares, M. Gavish, Z. Greenfeld, Y. Katz, B. G. Marcovici, C. G. Pick, Y. Rogel-Fuchs and A. Weizman. Neural and behavioral alterations after early exposure to phenobarbital. NeuroToxicology. 10:543-554 (1989).
20. Weizman, A., F. Fares, C.G. Pick, J. Yanai and M. Gavish. Chronic phenobarbital administration affects GABA and benzodiazepine receptors in the brain and peripheral. Eur. J. Pharmacology. 169:235-240 (1989).
21. Fares, F., A. Weizman, C.G. Pick, J. Yanai and M. Gavish. Effect of prenatal and neonatal chronic exposure to phenobarbital on central and peripheral benzodiazepine receptors. Brain Research. 506:115-119 (1990).
22. Paul, D., J.A. Levison, D.H. Howard, C.G. Pick, E.F. Hahn and G.W. Pasternak. Naloxone Benzoylhydrazone (NalBzoH) Analgesia. J. Pharmacology and Experimental Therapeutics. 255:769-774 (1990).
23. Yanai, J., C. G. Pick Y. Rogel-Fuchs, and E.A., Zahalka. Alterations in septohippocampal cholinergic receptors and related behavior after prenatal exposure to nicotine. In: K. Thurau and F. Adlkofer (Eds.) Effects of Nicotine on Biological Systems, Advances in Pharmacological Sciences. pp. 401-406, Birkhauser Verlag/Hamburg. (1991).
24. Paul, D., C.G. Pick, L.A. Tive and G.W. Pasternak. Pharmacological characterization of nalorphine, a kappa3 analgesic. J. Pharmacology and Experimental Therapeutics. 257:1-7 (1991).
25. Pick, C.G., Cheng, J. Paul, D. and Pasternak G.W. Genetic influences in opioid analgesia sensitivity in mice. Brain Research. 566:295-298 (1991).
26. Pick, C.G., Paul, D. and Pasternak G.W. Comparison of Naloxonazine and beta-funaltrexamine Antagonism of mu1 and mu2 Analgesia. Life Sciences. 48:2005-2011 (1991).
27. Pick, C.G., Paul, D. Eison, M.S. and Pasternak G.W. Potentiation of opioid analgesia by the antidepressant Nefazodone. Eur. J. Pharmacology. 211:375-381 (1992).
28. Froimowitz, M. Pick, C.G., and Pasternak G.W. Phenylmorphins and analogs: Opioid receptor subtype selectivity and effect of conformation on activity. J. Med. Chem. 35:1521-1525 (1992).
29. Tive, L.A., Pick, C.G., Paul, D., Roques, B.P., Gacel, G.A. and Pasternak G.W. Analgesia potency of Trimu-5: a mixed mu-2 agonist/mu-1 antagonist. Eur. J. Pharmacology. 216:249-255 (1992).
30. Pick, C.G., Roques, B.P., Gacel, G.A. and Pasternak G.W. Supraspinal mu-2 receptors mediate spinal/ supraspinal morphine synergy. Eur. J. Pharmacology. 220 275-277 (1992).
31. Tive, L.A., Ginsberg, K., Pick, C.G., and Pasternak G.W. Kappa3 receptors and levarphanol analgesia. Neuropharmacology. 31:851-856 (1992).
32. Pick, C.G., Paul, D. and Pasternak G.W. Nalbuphine, a mixed kappa1 and kappa3 analgesic in mice. J. Pharmacology and Experimental Therapeutics. 262:1044-1050 (1992).
33. Yanai, J., C.G. Pick, Y. Rogel-Fuchs, and E.A., Zahalka. Alterations in hippocampal cholinergic receptors and hippocampal behaviors after early exposure to nicotine. Brain Research Bulletin. 29:363-368 (1992).
34. Laviola, G., C.G. Pick, J. Yanai, and E. Alleva. Eight -arm maze performance, neophobia, and hippocampal cholinergic alterations after prenatal oxazepam in mice. Brain Research Bulletin. 29:609-616 (1992).
35. Yanai, J., Y. Avraham, S. Levi, J., Maslaton, C.G. Pick, Y. Rogel- Fuchs, and E.A., Zahalka. Alterations in septohippocampal cholinergic innervations and related behavior after early exposure to heroine and phencyclidine. Dev. Brain Research. 69:207-214 (1992).
36. Kolesnikov, Y.A., Pick, C.G. and Pasternak, G.W. NG-Nitro-L-arginine prevents morphine tolerance. Eur. J. Pharmacology. 221:399-400 (1992).
37. Yanai, J. Y. Rogel-Fuchs C. G. Pick, T. Slotkin, E.A., Zahalka and M.E,. Newman. Septohippocampal Cholinergic changes after destruction of the A10-septal Dopaminergic Pathways. Neuropharmacology 32:113-117 (1993).
38. Pick, C. G., Nejat, R. J. and Pasternak G.W. Independent expression of two pharmacologically distinct supraspinal mu analgesic systems in genetically different mouse strains. J. Pharmacology and Experimental Therapeutics. 265:166-171 (1993).
39. Pick, C.G., M. Cooperman, D. Natora, D. Trombka, and J. Yanai. Hippocampal cholinergic alternation and related behavioral deficits after early exposure to ethanol. J. Dev. Neuroscience. 11:379-385 (1993).
40. Pick, C.G, A. Weizman, F. Fares, M. Gavish, I, Kenner and J. Yanai. Hippocampal g- aminobutyric acid and benzodiazepine receptors after early phenobarbital exposure. Dev. Brain Research. 74:111-116 (1993). 41. Kolesnikov, Y.A., Pick, C.G., Ciszewska, G. and Pasternak, G.W. Blockade of tolerance to morphine but not kappa opioids by nitric oxide synthesis inhibitor. Proc. Natl. Acad. Sci. USA 90:5162-5166 (1993).
42. Katz, Y., Amiri, Z., Pick, C. G., Weizman, R., Yanai, J., and Gavish, M. Effect of chronic prenatal, neonatel and adult exposure to barbiturates on mitochondrial benzodiazepine receptors in mouse testis. Biochemical Pharmacology . 47: 910-913 (1994)
43. Shye, S., J. Yanai, and C.G. Pick. Directional consistency: Determinant of learned maze performance of five mice strains. Behavioral Processes. 32: 117-132 (1994).
44. Katz, Y., Weizman, A., Pick, C. G., Pasternak, G.W., Liu, L., Fonia, O. and Gavish, M. Interactions between laudanosine, GABA and brain opioid subtype receptors: implication for laudanosine seizure activity. Brain Res. 646: 235-241 (1994).
45. C. G., Pick, Antinociceptive interaction between alprazolam and opioids: Genetic Differences. Regulatory Peptides, 54:223-224 (1994).
46. Yanai, J., Shaanani, R. and Pick, C. G. Altered brain sensitivity to ethanol in mice after MPTP treatment. Alcohol, Alcohol. 12: 127-130 (1995).
47. Yanai, J. and C.G. Pick. Neuron transplantation into mice hippocampus alters their sensitivity to barbital. Brain Research Bulletin. 38: 93-98 (1995).
48. Schreiber, S., M.M. Backer and C.G. Pick. The opioid properties of a tetracyclic antidepressant. Analgesia. 1:707-710 (1995).
49. Schreiber, S. and C. G. Pick, Fluoxetine for blephrospasm: Interaction of serotonin and dopamine. Journal of Nervous and Mental Disease. 183: 719-721 (1995).
50. Pick, C. G., Genetic differences in mice analgesia: Interaction between alprazolam and opioid receptor subtype. Eur. Neuropsychopharmacology. 6: 201-206 (1996).
51. Schreiber, S., M.M. Backer and C.G. Pick. The antinociceptive effect of Fluvoxamine. Eur. Neuropsychopharmacology. In Press.
52. Schreiber, S., M.M. Backer, R., Weizman and C.G. Pick. The antinoceptive effects of Fluoxetine. The Pain Clinic. 9:349-356 (1996).
53. Pick, C.G., Peter, Y., Terkel, J., Gavish, M. and Weizman, R. The effect of a-THDOC a neuroactive steroid, on staircase test behavior in mice. Psychopharmacology. 128: 61-66 (1996).
54. Pick, C.G., Peter, Y., Schreiber, S. Weizman, R. Pharmacological Characterization of Buprenorphine, a Mixed Agonist - Antagonist with Kappa3 Analgesia. Brain Research. 744: 41-46 (1997).
55. Pick, C. G., Antinociceptive interaction between alprazolam and opioids. Brain Research Bulletin. 42: 239-243 (1997).
56. Schreiber, S. and Pick, C. G. Paroxetine for secondary stuttering: further interaction of serotonin and dopamine. Journal of Nervous and Mental Disease. In Press.
57. Pick, C.G., Peter, Y., Schreiber, S., Gavish, M. and Weizman, R. Effect of the GABA active agents muscimol and alphaxlone on staircase test behavior in mice. Brain Research, In Press.
58. Backer, M.M., Schreiber, S. and C.G. Pick. Interaction between antidepressant and morphine alter gastrointestinal transit. Life Sciences, 61: PL109- PL 113 (1997).
59. Schreiber, S., M.M. Backer, R., Weizman and C.G. Pick. Interaction between the atypical antipsychotic drug risperidone and opioids. Neuroscience Letters, 228: 25-28 (1997).
60. Weizman, R.. Pankova, I.A., Schreiber, S. and Pick, C. G. Flunarizine analgesia is mediated by mu opioid receptor. Physiology & Behavior. In press.
MANUSCRIPTS SUBMITTED FOR PUBLICATION
61. Schreiber, S., M.M. Backer and C.G. Pick. Interaction between the
tetracyclic antidepressant Mianserin HCL and opioids.
62. Schreiber, S., S. Vinokur, V, Shavelzon, C. G., Pick, and Y. Shir. The use of fluoxetine for chronic pain management: A six weeks study with amitriptyline.